1,372
Participants
Start Date
September 30, 2007
Primary Completion Date
September 30, 2013
Study Completion Date
September 30, 2013
botulinum toxin type A
There will be no protocol-mandated intervention with regard to physician treatment choice or management of patient condition once the patient is enrolled in the project.
Toronto
Lead Sponsor
Allergan
INDUSTRY